Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Novel Variants Broaden the Phenotypic Spectrum of Plekhg5-Associated Neuropathies Publisher Pubmed



Chen Z1, 2 ; Maroofian R2 ; Basak AN3 ; Shingavi L4 ; Karakaya M5 ; Efthymiou S2 ; Gustavsson EK1 ; Meier L5 ; Polavarapu K4, 6, 7, 8 ; Vengalil S4 ; Preethishkumar V4 ; Nandeesh BN9 ; Gokce Gunes N10 ; Akan O11 Show All Authors
Authors
  1. Chen Z1, 2
  2. Maroofian R2
  3. Basak AN3
  4. Shingavi L4
  5. Karakaya M5
  6. Efthymiou S2
  7. Gustavsson EK1
  8. Meier L5
  9. Polavarapu K4, 6, 7, 8
  10. Vengalil S4
  11. Preethishkumar V4
  12. Nandeesh BN9
  13. Gokce Gunes N10
  14. Akan O11
  15. Candan F12
  16. Schrank B13
  17. Zuchner S14
  18. Murphy D2
  19. Kapoor M2
  20. Ryten M1
  21. Wirth B5
  22. Reilly MM2
  23. Nalini A4
  24. Houlden H2
  25. Sarraf P15
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, University College London, London, United Kingdom
  2. 2. Department of Neuromuscular Disease, University College London Queen Square Institute of Neurology, University College London, London, United Kingdom
  3. 3. School of Medicine, Neurodegeneration Research Laboratory, KUTTAM-NDAL, Koc University, Istanbul, Turkey
  4. 4. Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India
  5. 5. Institute of Human Genetics, Center for Molecular Medicine and Center for Rare Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany
  6. 6. Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada
  7. 7. Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada
  8. 8. Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada
  9. 9. Department of Neuropathology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India
  10. 10. Neurology Department, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey
  11. 11. Neurology Department, Okmeydani Training and Research Hospital, Istanbul, Turkey
  12. 12. Neurology Department, Goztepe Training and Research Hospital, Medeniyet University, Istanbul, Turkey
  13. 13. Department of Neurology, DKD Helios Kliniken, Wiesbaden, Germany
  14. 14. Department of Human Genetics and Hussman Institute for Human Genomics, University of Miami Miler School of Medicine, Miami, FL, United States
  15. 15. Department of Neuromuscular Diseases, Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: European Journal of Neurology Published:2021


Abstract

Background and purpose: Pathogenic variants in PLEKHG5 have been reported to date to be causative in three unrelated families with autosomal recessive intermediate Charcot-Marie-Tooth disease (CMT) and in one consanguineous family with spinal muscular atrophy (SMA). PLEKHG5 is known to be expressed in the human peripheral nervous system, and previous studies have shown its function in axon terminal autophagy of synaptic vesicles, lending support to its underlying pathogenetic mechanism. Despite this, there is limited knowledge of the clinical and genetic spectrum of disease. Methods: We leverage the diagnostic utility of exome and genome sequencing and describe novel biallelic variants in PLEKHG5 in 13 individuals from nine unrelated families originating from four different countries. We compare our phenotypic and genotypic findings with a comprehensive review of cases previously described in the literature. Results: We found that patients presented with variable disease severity at different ages of onset (8–25 years). In our cases, weakness usually started proximally, progressing distally, and can be associated with intermediate slow conduction velocities and minor clinical sensory involvement. We report three novel nonsense and four novel missense pathogenic variants associated with these PLEKHG5-associated neuropathies, which are phenotypically spinal muscular atrophy (SMA) or intermediate Charcot-Marie-Tooth disease. Conclusions: PLEKHG5-associated neuropathies should be considered as an important differential in non-5q SMAs even in the presence of mild sensory impairment and a candidate causative gene for a wide range of hereditary neuropathies. We present this series of cases to further the understanding of the phenotypic and molecular spectrum of PLEKHG5-associated diseases. © 2020 European Academy of Neurology
Other Related Docs
11. A Bioinformatics Approach to Prioritize Single Nucleotide Polymorphisms in Tlrs Signaling Pathway Genes, International Journal of Molecular and Cellular Medicine (2016)
20. Identification of Six Novel Mutations in Iranian Patients With Maple Syrup Urine Disease and Their in Silico Analysis, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (2016)